Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral antidiabetic drug metabolism: pharmacogenomics and drug interactions
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 5, Issue 3, Pages 225-241
Publisher
Informa Healthcare
Online
2009-03-31
DOI
10.1517/17425250902806424
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of pharmacokinetic and pharmacodynamic interaction between the dipeptidyl peptidase IV inhibitor vildagliptin, glyburide and pioglitazone in patients with Type 2 diabetes
- (2011) D. Serra et al. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
- Reduction of the acute bioavailability of metformin by the α-glucosidase inhibitor acarbose in normal man
- (2010) A. J. SCHEEN et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine
- (2010) Zhi-Jun Wang et al. Pharmacogenetics and Genomics
- Cardiovascular Outcomes in Trials of Oral Diabetes Medications
- (2008) Elizabeth Selvin et al. ARCHIVES OF INTERNAL MEDICINE
- Sitagliptin, an dipeptidyl peptidase-4 inhibitor, does not alter the pharmacokinetics of the sulphonylurea, glyburide, in healthy subjects
- (2008) Goutam C. Mistry et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Effect of food on the pharmacokinetics of a vildagliptin/metformin (50/1000 mg) fixed-dose combination tablet in healthy volunteers
- (2008) Yan-Ling He et al. CURRENT MEDICAL RESEARCH AND OPINION
- Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes
- (2008) Itamar Raz et al. CURRENT MEDICAL RESEARCH AND OPINION
- Is the Combination of Sulfonylureas and Metformin Associated With an Increased Risk of Cardiovascular Disease or All-Cause Mortality?: A meta-analysis of observational studies
- (2008) A. D. Rao et al. DIABETES CARE
- Effects of vildagliptin on glucose control in patients with type 2 diabetes inadequately controlled with a sulphonylurea*
- (2008) A. J. Garber et al. DIABETES OBESITY & METABOLISM
- Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial
- (2008) C. Pan et al. DIABETIC MEDICINE
- Long-term adherence to statin treatment in diabetes
- (2008) L. A. Donnelly et al. DIABETIC MEDICINE
- Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use
- (2008) D. P. Kao et al. DIABETIC MEDICINE
- Beta cell mass in diabetes: a realistic therapeutic target?
- (2008) J. J. Meier DIABETOLOGIA
- Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy
- (2008) D. M. Nathan et al. DIABETOLOGIA
- Metformin and the intestine
- (2008) C. J. Bailey et al. DIABETOLOGIA
- Interindividual variability in oral antidiabetic drug disposition and response: the role of drug transporter polymorphisms
- (2008) Michael A Pacanowski et al. Expert Opinion on Drug Metabolism & Toxicology
- Pharmacokinetics and Pharmacodynamics of Vildagliptin in Healthy Chinese Volunteers
- (2008) Pei Hu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Paget's Disease of the Mandible
- (2008) Mayank B. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Intensive Glucose Lowering in Type 2 Diabetes
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
- (2008) Peter Gæde et al. NEW ENGLAND JOURNAL OF MEDICINE
- 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes
- (2008) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Polymorphism in human organic cation transporters and metformin action
- (2008) Hiroshi Takane et al. PHARMACOGENOMICS
- No significant effect ofSLCO1B1polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone
- (2007) Annikka Kalliokoski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Vildagliptin, a Novel Dipeptidyl Peptidase IV Inhibitor, Has No Pharmacokinetic Interactions With the Antihypertensive Agents Amlodipine, Valsartan, and Ramipril in Healthy Subjects
- (2007) Yan-Ling He et al. JOURNAL OF CLINICAL PHARMACOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now